Huadong Medicine | Briefing, News, Analysis, Research, Data

Huadong Medicine

Huadong Medicine is a comprehensive pharmaceuticals company.

Huadong Medicine, founded in March 1993 and headquartered in Hangzhou, is a comprehensive manufacturer and distributor of various types of antibiotics, proprietary Chinese medicines, and synthetic drugs. The founder is Lu Liang. Listed on the Shenzhen Stock Exchange on January 27, 2020, the company's major shareholders are China Grand Enterprises and Hangzhou Huadong Medicine. The direct and indirect competitors of Huadong Medicine include Hengrui Medicine, Humanwell Healthcare, Kelun Pharmaceutical.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Large Pharma

Founded

Mar 31, 1993

HQ location

Zhejiang, China

Legal name

Huadong Medicine Co., Ltd.

Website

http://www.eastchinapharm.com

hz000963@126.com

Employees

10944

All
News
Analysis
Research

Briefing Jun 24, 2022 11:15 AM · Healthcare

F-star to be acquired by China biopharmaceutical with USD 161million

Briefing Feb 23, 2022 10:59 AM · Financials | Technology | Consumer Staples

Yimei concept stocks rose and strengthened, and Aoyang health once touched the board

In-depth

Healthcare

Immunotherapy in China: A Rising Star in the Field of Cancer Treatment

Immunotherapy is emerging as a powerful weapon in fighting cancer by restarting and maintaining the cancer-immunity cycle to identify, control and eliminate tumor cells rather than killing them directly.

Nov 24, 2022 06:29 PM

Briefing Jan 21, 2022 04:09 AM · Technology | Financials

Google will ask the EU supreme judge to clarify relevant laws on the issue of a fine of 2.4 billion euros.

Briefing Dec 28, 2021 07:40 PM · Technology | Consumer Discretionary | Healthcare

Kailong high tech: it plans to subscribe for the shares issued by Jingsheng with a targeted amount of 999932 yuan

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Consumer Staples, Healthcare, Technology

WIA2020 | Rising Tech Stars 2020: Global & China's 100

Dec 09, 2020 09:57 AM

Briefing Dec 21, 2021 01:29 PM · Technology | Healthcare

Power stocks warmed up in the afternoon

Briefing Dec 03, 2021 06:09 PM · Technology | Healthcare | Financials

4. Banking and insurance institutions shall not provide trading services for non hedging purposes for enterprises

Briefing Nov 11, 2021 08:29 PM · Technology | Consumer Staples | Healthcare

Apple IOS will add a "Digital Heritage" function to specify contacts to inherit icloud data

Briefing Oct 29, 2021 11:38 AM

Financial Associated Press, October 29 - a carbon monoxide poisoning accident occurred in an ironmaking plant in Xingtai, Hebei Province. Three people died after ineffective rescue.

Insight

Healthcare

Challenges and Opportunities Possessed by Digital Therapeutics Industry

Following the digital therapeutics series report, this article is centered on the challenges and opportunities faced by the digital therapeutics industry and aims to provide insights on the two above aspects.

Nov 23, 2022 03:23 PM

Healthcare

Yaohabio Secures Over CNY 100 Mn in the Series B+ Round

A full-scale CRDMO combines a CRO and CDMO business model, resulting in a fully integrated suite of end-to-end solutions to meet future market demand.

Nov 21, 2022 07:06 PM

Briefing Oct 08, 2021 10:18 AM · Technology | Healthcare

Lansi Technology: the decrease in the price of customers' products does not mean the decline in the price of products supplied by the company

Briefing Sep 29, 2021 07:13 PM · Technology | Healthcare | Automotive

East China medicine: the subsidiary ornidazole tablets passed the conformity evaluation of generic drugs

Briefing Sep 05, 2021 04:23 PM · Consumer Staples | Healthcare | Financials

Qianhe flavor industry: there is no cross period adjustment cost

Healthcare

Junshi Biosciences Submitted MAA to EMA for Toripalimab for NPC and ESCC

Toripalimab, an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences, is about to land the European market.

Nov 15, 2022 04:34 PM

Insight

Healthcare

EqualOcean 2022 China AI Health 30 Companies list Reveals

Starting from September 2022, EqualOcean had been conducting deep market research and expert interviews aiming to select out 30 most representative China-based companies in the AI Health sector that are with the most growth and development potential. It is finally officially finalized, and we give our deep and sincere congratulations to those 30 companies and wish them all the best in the future.

Nov 09, 2022 01:00 AM

Briefing Aug 27, 2021 10:39 PM · Technology | Healthcare

Huadong pharmaceutical receives the regulatory inquiry letter: it is required to explain the specific situation of the dispute related to the dissolution between Huadong pharmaceutical and Ningbo

Briefing Jul 06, 2021 10:41 AM · Healthcare

Yimei concept stocks all weakened, Aoyuan Meigu closed down

Briefing Jun 25, 2021 09:58 AM · Technology | Healthcare

The medical beauty sector is stronger again, and aimike is reaching a new high

Briefing Jun 22, 2021 05:58 PM · Technology | Consumer Discretionary | Healthcare

project

EqualOcean Analysis